MedPath

Behavioral Activation for Depression Through Virtual Reality

Not Applicable
Conditions
Depression
Interventions
Other: Behavioral activation using virtual reality
Registration Number
NCT05138744
Lead Sponsor
Universitat Jaume I
Brief Summary

Evaluate the effectiveness of a brief, virtual reality intervention for depressed mood

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
8
Inclusion Criteria
  • Patient Health Questionnaire - 9 (measure of depression) over 9
  • Positive and Negative Affect Schedule (measure of positive and negative affect): positive affect score below 24
  • Age over 18 years
  • Signs informed consent
Exclusion Criteria
  • Completes more than 20% of evaluations retrospectively (not the day they are assigned)
  • Has a severe mental health disorder as evaluated with the MINI International Neuropsychiatric Interview
  • Does not sign the informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Virtual reality treatmentBehavioral activation using virtual realityUse of google maps with virtual reality to virtually situate the participants into scenarios that are motivating for them (i.e., the beach, a mountain, a park, etc.) at their choice.
Primary Outcome Measures
NameTimeMethod
Change in Behavioral activationChange through study completion, an average of 31 days. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline vs posttreatment)

In a scale from 0 (not at all) to 6 (completely), "to what extent were you satisfied with what you did today?"

Secondary Outcome Measures
NameTimeMethod
Change in Activity levelChange through study completion, an average of 31 days.. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)

In a scale from 0 (minimum) to 100 (maximum), "what was your activity level today?"

Change in DepressionChange through study completion, an average of 31 days.. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)

In a scale from 0 (not at all) to 3 (completely), "how was your level of depression today?"

Change in MoodChange through study completion, an average of 31 days. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)

In a scale from 0 (completely sad) to 100 (completely happy), "how did you feel today?"

Change in Positive affectChange through study completion, an average of 31 days.. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)

In a scale from 1 (not at all) to 5 (completely), "how was your positive affect today?"

Change in Negative affectChange through study completion, an average of 31 days.. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)

In a scale from 1 (not at all) to 5 (completely), "how was your negative affect today?"

© Copyright 2025. All Rights Reserved by MedPath